Tcw Group Inc Karyopharm Therapeutics Inc. Transaction History

Tcw Group Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 11, 2019	SELL	$8.2 - $16.95 $211,387 - $436,954	-25,779 Closed	0 $0
Q3 2018 Oct 30, 2018	SELL	$17.03 - $21.18 $323 - $402	-19 Reduced 0.07%	25,779 $439,000
Q2 2018 Aug 02, 2018	SELL	$12.0 - $19.88 $211,800 - $350,882	-17,650 Reduced 40.62%	25,798 $438,000
Q1 2018 May 11, 2018	BUY	$9.92 - $17.25 $27,776 - $48,300	2,800 Added 6.89%	43,448 $583,000
Q2 2017 Aug 11, 2017	BUY	N/A	40,648	40,648 $368,000

57.6M

258K

81.2K

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $55.9M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

Get notified when there are updates to the investment portfolio of Tcw Group Inc, based on Form 13F filings with the SEC.

Stay updated on Tcw Group Inc with notifications on news.